Success Metrics

Clinical Success Rate
83.3%

Based on 5 completed trials

Completion Rate
83%(5/6)
Active Trials
0(0%)
Results Posted
20%(1 trials)
Terminated
1(10%)

Phase Distribution

Ph phase_1
2
20%
Ph not_applicable
5
50%
Ph phase_4
2
20%
Ph phase_3
1
10%

Phase Distribution

2

Early Stage

0

Mid Stage

3

Late Stage

Phase Distribution10 total trials
Phase 1Safety & dosage
2(20.0%)
Phase 3Large-scale testing
1(10.0%)
Phase 4Post-market surveillance
2(20.0%)
N/ANon-phased studies
5(50.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

71.4%

5 of 7 finished

Non-Completion Rate

28.6%

2 ended early

Currently Active

0

trials recruiting

Total Trials

10

all time

Status Distribution
Active(1)
Completed(5)
Terminated(2)
Other(2)

Detailed Status

Completed5
unknown2
Not yet recruiting1
Terminated1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
0
Success Rate
83.3%
Most Advanced
Phase 4

Trials by Phase

Phase 12 (20.0%)
Phase 31 (10.0%)
Phase 42 (20.0%)
N/A5 (50.0%)

Trials by Status

not_yet_recruiting110%
unknown220%
terminated110%
completed550%
withdrawn110%

Recent Activity

Clinical Trials (10)

Drug Details

Intervention Type
DRUG
Total Trials
10